IL271256A - Preparations and methods for the treatment of teopathy - Google Patents
Preparations and methods for the treatment of teopathyInfo
- Publication number
- IL271256A IL271256A IL271256A IL27125619A IL271256A IL 271256 A IL271256 A IL 271256A IL 271256 A IL271256 A IL 271256A IL 27125619 A IL27125619 A IL 27125619A IL 271256 A IL271256 A IL 271256A
- Authority
- IL
- Israel
- Prior art keywords
- compositions
- methods
- treating tauopathies
- tauopathies
- treating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2017/037991 WO2018231254A1 (en) | 2017-06-16 | 2017-06-16 | Compositions and methods for treating tauopathies |
Publications (1)
Publication Number | Publication Date |
---|---|
IL271256A true IL271256A (en) | 2020-01-30 |
Family
ID=59388133
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL271256A IL271256A (en) | 2017-06-16 | 2019-12-08 | Preparations and methods for the treatment of teopathy |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP3638694A1 (es) |
JP (2) | JP2020529394A (es) |
KR (1) | KR20200018502A (es) |
CN (1) | CN110770253A (es) |
AU (1) | AU2017418317A1 (es) |
BR (1) | BR112019026298A2 (es) |
CA (1) | CA3064550A1 (es) |
EA (1) | EA202090063A1 (es) |
IL (1) | IL271256A (es) |
MX (1) | MX2019015071A (es) |
WO (1) | WO2018231254A1 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6674888B2 (ja) | 2013-03-13 | 2020-04-01 | プロセナ バイオサイエンシーズ リミテッド | タウ免疫療法 |
EA201892417A1 (ru) | 2016-05-02 | 2019-05-31 | Протена Биосайенсис Лимитед | Антитела, распознающие тау |
FI3452507T3 (fi) | 2016-05-02 | 2022-12-15 | Tau-immuunihoito | |
WO2018152359A1 (en) | 2017-02-17 | 2018-08-23 | Denali Therapeutics Inc. | Anti-tau antibodies and methods of use thereof |
CN110881274A (zh) | 2017-05-02 | 2020-03-13 | 普罗塞纳生物科学有限公司 | 识别tau的抗体 |
BR112021016947A2 (pt) | 2019-03-03 | 2021-11-03 | Prothena Biosciences Ltd | Anticorpos que reconhecem tau |
CN117716034A (zh) | 2021-07-27 | 2024-03-15 | 斯坦德治疗有限公司 | 肽标签和编码该肽标签的核酸 |
KR20230172262A (ko) | 2022-06-15 | 2023-12-22 | 재단법인대구경북과학기술원 | Ptk2 억제제를 유효성분으로 포함하는 타우병증의 예방 또는 치료용 조성물 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4634665A (en) | 1980-02-25 | 1987-01-06 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
US5179017A (en) | 1980-02-25 | 1993-01-12 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
US5827690A (en) | 1993-12-20 | 1998-10-27 | Genzyme Transgenics Corporatiion | Transgenic production of antibodies in milk |
SI2331090T1 (en) * | 2008-09-19 | 2018-04-30 | Pfizer Inc. | Stable liquid antibody formulation |
EA031698B1 (ru) * | 2010-10-11 | 2019-02-28 | Байоджен Интернэшнл Нейросайенз Гмбх | Человеческие анти-тау антитела |
JP5941770B2 (ja) | 2012-06-28 | 2016-06-29 | 株式会社ミマキエンジニアリング | インクジェット記録装置、液体供給装置および記録ヘッドのクリーニング方法 |
BR112015003326A2 (pt) * | 2012-08-16 | 2017-07-04 | Ipierian Inc | métodos de tratamento de uma tauopatia |
EA039554B1 (ru) * | 2013-06-10 | 2022-02-09 | АйПИЕРИАН, ИНК. | Способ снижения уровней a40 и/или a42 в нервной клетке и/или во внеклеточной жидкости |
BR112016010454A2 (pt) * | 2013-11-27 | 2017-12-05 | Ipierian Inc | métodos para tratar uma taupatia |
WO2016059512A1 (en) * | 2014-10-18 | 2016-04-21 | Pfizer Inc. | Anti-il-7r antibody compositions |
-
2017
- 2017-06-16 CA CA3064550A patent/CA3064550A1/en active Pending
- 2017-06-16 EA EA202090063A patent/EA202090063A1/ru unknown
- 2017-06-16 EP EP17743107.9A patent/EP3638694A1/en not_active Withdrawn
- 2017-06-16 WO PCT/US2017/037991 patent/WO2018231254A1/en active Application Filing
- 2017-06-16 MX MX2019015071A patent/MX2019015071A/es unknown
- 2017-06-16 CN CN201780091913.0A patent/CN110770253A/zh active Pending
- 2017-06-16 AU AU2017418317A patent/AU2017418317A1/en not_active Abandoned
- 2017-06-16 BR BR112019026298-9A patent/BR112019026298A2/pt unknown
- 2017-06-16 JP JP2019569225A patent/JP2020529394A/ja active Pending
- 2017-06-16 KR KR1020197038545A patent/KR20200018502A/ko not_active Application Discontinuation
-
2019
- 2019-12-08 IL IL271256A patent/IL271256A/en unknown
-
2021
- 2021-11-10 JP JP2021182954A patent/JP2022033757A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
KR20200018502A (ko) | 2020-02-19 |
WO2018231254A1 (en) | 2018-12-20 |
MX2019015071A (es) | 2020-02-13 |
CN110770253A (zh) | 2020-02-07 |
AU2017418317A1 (en) | 2019-12-05 |
EA202090063A1 (ru) | 2020-04-03 |
JP2022033757A (ja) | 2022-03-02 |
JP2020529394A (ja) | 2020-10-08 |
CA3064550A1 (en) | 2018-12-20 |
EP3638694A1 (en) | 2020-04-22 |
BR112019026298A2 (pt) | 2020-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL267247B (en) | Compositions and methods for treating cancer | |
IL269150A (en) | Preparations and methods for the treatment of cancer | |
HK1256602A1 (zh) | 用於治療翼狀胬肉的組合物和方法 | |
IL263224A (en) | Methods and preparations for the treatment of cancer | |
IL266053A (en) | Preparations and methods for the treatment of ezh2-mediated cancer | |
IL271256A (en) | Preparations and methods for the treatment of teopathy | |
GB2578539B (en) | Compositions and methods for preventing or treating muscle conditions | |
IL263460A (en) | Preparations and methods for the treatment of cardiovascular diseases | |
IL268684A (en) | Preparations and methods for immuno-oncology | |
IL274837A (en) | Methods and preparations for the treatment of cancer | |
IL269157A (en) | Preparations and methods for the treatment of cancer | |
PT3261644T (pt) | Composições e métodos para tratar a degradação retinal | |
IL269637A (en) | Preparations and methods for the treatment of synovial diseases | |
HK1258825A1 (zh) | 用於治療多汗症的方法和組合物 | |
IL274524A (en) | Preparations and methods for aquaculture | |
EP3519058C0 (en) | HAIR TREATMENT COMPOSITIONS AND METHODS | |
PL3280423T3 (pl) | Kompozycje i sposoby do synergistycznego leczenia glikokaliksu | |
PL3402575T3 (pl) | Sposoby i kompozycje do traktowania zniszczonych włosów | |
IL272246A (en) | Preparations and methods for treating galactosemia | |
SG11202012055PA (en) | Methods and compositions for preventing or treating calciphylaxis | |
IL291266A (en) | Preparations and methods for treating infections | |
HK1256541A1 (zh) | 用於處理皮膚的方法和組合物 | |
IL269743A (en) | Methods and preparations for the treatment of disease related to the retina with CCR-3 inhibitor inventions | |
SG10202013112YA (en) | Zinc-gamma-pga compositions and methods for treating cancer | |
EP3262065C0 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF DYSTROGLYCANOPATHY DISEASES |